Serum Institute buys polio vaccine co in Czech for 72 mn euros

Image
Press Trust of India Mumbai
Last Updated : Apr 25 2017 | 1:42 PM IST
Serum Institute of India today acquired the defunct unit in Czech of Florida-based Nanotherapeutics that makes injectable polio doses for 72 million euros.
The acquisition would catapult the Pune-based company to the largest injectable polio vaccine maker in the world with over 200 million doses, a senior official claimed.
The plant at Bohumil, which is one hour off the Czech Republic capital Prague, is not functional now and Serum Institute will have to invest an additional 30-40 million euros to make it functional, Serum Institute of India's Chief Executive Officer Adar C Poonawalla told PTI.
Poonawalla said the company has already paid 45 million euros for the plant and the remaining will be paid one year later.
Serum Institute is the world's largest vaccine manufacturer by number of doses produced and sold globally.
"This acquisition will add to our injectable polio capacity by four times to a total of 200 million doses by 2019, making us the largest injectable (not oral) polio vaccine manufacturer in the world," Poonawalla said.
The current acquisition by the company is the second one overseas since 2012 when it bought a plant in Holland.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 25 2017 | 1:42 PM IST

Next Story